Delivery Order SPE2DB22D2206-SPE2DB25FHG72
- Not listed
- The Defense Logistics Agency awarded a $13,963.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for Talvey 40 mg/ml vials, with an ultimate completion date of August 14, 2025. This non-set-aside competitive award was issued on July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,926.36 to AmerisourceBergen Drug Corp for TALVEY 40 mg/ml vials. This firm fixed-price, competitively awarded delivery order (Contract No. 4569329234) was issued on September 4, 2025, with an ultimate completion date of September 25, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a $20,418.90 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Talvey 40 mg/mL vial. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency awarded a $27,926.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALVEY 40 mg/mL vials, with an ultimate completion date of September 2, 2025. This non-set-aside competitive award, issued on August 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $27,225.24 firm fixed price delivery order is for the supply of Talvey 40 mg/ml vials, a pharmaceutical product. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through December 31, 2025....
- This is a $6,981.59 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALVEY 40 MG/ML VIALML, a medical product, with a performance period through June 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,963.18 firm fixed-price delivery order is for the supply of 'TALVEY 40 MG/ML VIALML' medical products. The contract has an ultimate completion date of March 6, 2025 and is not set aside for any specific business category. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,947.09 firm fixed-price delivery order is for the supply of "TALVEY 40 MG/ML VIALML" pharmaceutical products. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for TALVEY 40 MG/ML VIALML, with a potential value of $27,225.24 and a completion date of February 2, 2024. No set-aside designation was used. AmerisourceBergen Drug Corp has an established history of providing pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,494.30, is for the delivery of TALVEY 3 MG/1.5 ML VIAL 1.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 9, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHG72Delivery Order
The Defense Logistics Agency awarded a $13,963.18 delivery order to AmerisourceBergen Drug Corp for Talvey 40 mg/ml vials under a firm fixed price contract type. This delivery order, with an ultimate completion date of June 27, 2025, represents a child contract issued against the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, and performance is based at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency, supplying a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order for Talvey, an oncology medication, exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through the flexible DLA Troop Support Medical prime vendor contract vehicle, which enables global pharmaceutical supply capabilities to military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 6/5/25 |